Clinical trial
Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in Reanimation
NCT03979625 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in Reanimation
- Lead sponsor
- Central Hospital, Nancy, France
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2016
- Completion date
- April 30, 2018
- Enrollment
- 39 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
heparin-induced thrombocytopenia